Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
Iwate University: Contribution of’Cacerpillar fungus’ substance: dementia and Alzheimer’s disease
First EU Nation To Approve Ivermectin For Covid-19
COVID-19: Dr. Reddy ’s completes AVIGAN trial in Kuwait: therapeutic effect in early infection